Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation

Amwell® (NYSE: AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms Industry. The recognition validates Amwell's ability to address healthcare fragmentation through a unified platform that orchestrates consumer experiences, clinician workflows, care programs, and partner solutions.

“Our vision is that healthcare works better when technology brings the ecosystem together,” said Dan Zamansky, Chief Product and Technology Officer at Amwell. “We're building the integrated infrastructure that connects patients, providers, health plans, and virtual care solutions, and this award reflects our commitment to that mission.”

The recognition followed a 12-month analytical process that evaluated Amwell across two dimensions: technology leverage — including innovation, creativity, development efficiency, commercialization, and application diversity; and business impact — including financial performance, customer acquisition, operational efficiency, growth potential, and human capital. The evaluation shows that Amwell's platform approach delivers measurable results for customers.

Sagar Mukhekar, Industry Analyst at Frost & Sullivan said, “The combination of reliability, flexibility, and clinically integrated workflows positions the Amwell Platform as a strategic enabler for organizations seeking to reduce fragmentation, improve member engagement with covered programs, expand access to care, and create more connected healthcare experiences.”

Healthcare organizations have expanded their digital capabilities over time, but this growth often creates new problems. Virtual care, condition management, remote monitoring, and digital therapeutics can operate as disconnected point solutions, resulting in fragmented patient experiences, duplicate processes, and significant administrative burden. Amwell offers a different approach by providing a connected foundation that unifies consumer interactions, clinician workflows, care programs, and partner ecosystems within a common architecture.

About Amwell Amwell offers health plans and healthcare organizations a single, comprehensive, technology-enabled care platform. We use technology to provide consumers with better access to more convenient, affordable, and effective care. The Amwell Platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows consumers to experience unified, personalized, and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell Platform is proven, operating at a large scale, enabling care for millions while delivering dependable outcomes. For two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn .

Forward-Looking Statements

This article contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements about the future of digital health, the role of artificial intelligence, data, and automation in care delivery, and Amwell’s strategy and priorities. These statements reflect current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including those described under “Risk Factors” in Amwell’s most recent Annual Report on Form 10-K and in subsequent Quarterly Reports on Form 10-Q, available at investors.amwell.com. Amwell undertakes no obligation to update any forward-looking statement.

Investors: Asher Dewhurst [email protected]

Media: [email protected]